Apixaban, a possible treatment option for a "ghost" left behind after transvenous lead extraction.

Isawa, Tsuyoshi; Nomura, Takehiro; Honda, Taku; Yamaya, Kazuhiro; Toyoda, Shigeru

Isawa, Tsuyoshi; Nomura, Takehiro; Honda, Taku; Yamaya, Kazuhiro; Toyoda, Shigeru.

Afiliación

Isawa T; Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan. Electronic address: isa_tsuyo@yahoo.co.jp.
Nomura T; Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.
Honda T; Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.
Yamaya K; Department of Cardiovascular Surgery, Sendai Kousei Hospital, Sendai, Japan.
Toyoda S; Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan.

Can J Cardiol ; 2024 Jun 21.

Article en En | MEDLINE | ID: mdl-38909887

Palabras clave

apixaban; direct oral anticoagulants; ghost; lead extraction

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Can J Cardiol Asunto de la revista: CARDIOLOGIA Año: 2024 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google